FRISCO, Texas—Soleo Health, a national provider of complex specialty pharmacy services, announced the launch of SoleoRare, its rare disease specialty pharmacy. The new brand brings together experienced rare disease patient care, patient access and commercial teams under a differentiated care model that is clinician‑led, patient‑centered and built for the unique demands of rare, ultra-rare and orphan disease patients and their caregivers.
The company said over the years it has invested in clinical expertise, patient support capabilities and the commercial infrastructure necessary to serve this population with the rigor it demands. The company added the launch of SoleoRare reflects that ongoing commitment, uniting dedicated resources to deliver exceptional outcomes for patients, caregivers, providers, payers and pharmaceutical manufacturer partners.
“Rare disease patients require more than a standard pharmacy experience; they deserve a dedicated care team that truly understands their journey,” said Drew Walk, chief executive officer of Soleo Health. “SoleoRare is the natural evolution of everything we have built. It highlights our rare disease capabilities, experience and expertise.”
“Pharma partners developing rare and orphan therapies require a more specialized distribution channel, they need a true clinical and commercial partner,” said Craig Vollmer, chief commercial officer. “SoleoRare was built to be exactly that. With dedicated teams focused on rare disease, we are positioned to deliver a meaningful impact on our patients’ experience.”